Olema Pharmaceuticals, Inc. (OLMA)
13.67
-0.45
(-3.19%)
USD |
NASDAQ |
Mar 27, 16:00
13.67
0.00 (0.00%)
After-Hours: 20:00
Olema Pharmaceuticals Shareholders Equity (Quarterly) : 478.56M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| EyePoint Plc | 306.11M |
| CytomX Therapeutics, Inc. | 99.01M |
| Corvus Pharmaceuticals, Inc. | 61.20M |
| Protagonist Therapeutics, Inc. | 614.71M |
| Oric Pharmaceuticals, Inc. | 384.36M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 677.32M |
| Total Liabilities (Quarterly) | 198.76M |
| Debt to Equity Ratio | 0.0088 |
| Current Ratio | 9.950 |
| Net Debt Paydown Yield | -0.02% |